Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth
Learn MoreShervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth
Learn MoreThe Conference Call on Q3 2026 takes place on November 3, 2026
Learn MoreFresenius Medical Care at ASN Kidney Week 2026
Learn MoreExplore our new careers site and discover meaningful opportunities to help lead the future of kidney care.
Learn MoreHighVolumeHDF Therapy: Transforming the Standard of Kidney Care
Learn MoreFresenius Medical Care publishes its key financial figures for the third quarter of 2026 on November 3, 2026
Learn More